Arena shares slump 14 pct before diet drug ruling

(Reuters) - Shares of Arena Pharmaceuticals Inc fell 15 percent on Friday, days ahead of a key meeting at which U.S. regulators will rule on whether to approve its experimental weight-loss drug.

data room direct